Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degeneration

Abstract Background Anti–vascular endothelial growth factor (anti-VEGF) agents have become the standard of care in neovascular age-related macular degeneration (nAMD). Despite generally excellent response rates to anti-VEGF therapy, some patients do not respond or may respond suboptimally. In the ca...

Full description

Bibliographic Details
Main Authors: Sam Razavi, Laurent Kodjikian, Audrey Giocanti-Aurégan, Ingrid Dufour, Eric Souied
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Ophthalmology
Subjects:
Retina
Age-related macular degeneration
Exudative
Switch
Observational
Online Access:https://doi.org/10.1186/s12886-021-01841-6

Internet

https://doi.org/10.1186/s12886-021-01841-6

Similar Items